Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity
12/05/2026 14:07
May 12 (Reuters) - Vyome Holdings Inc HIND.O: VYOME STRIKES DEAL WITH IMPETIS BIOSCIENCES, OPENING A ~$57B MARKET OPPORTUNITY VYOME HOLDINGS INC - RECEIVES EXCLUSIVE LICENSE FOR SELECTIVE JAK 1/3 AND JAK1 INHIBITORS Source text: ID:nBw9Cyszta Further company coverage: HIND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity